Cargando…
Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that eventually leads to dementia and death of the patient. Despite the enormous amounts of resources and efforts for AD drug development during the last three decades, no effective treatments have been developed that can slow or h...
Autores principales: | Gong, Cheng-Xin, Dai, Chun-Ling, Liu, Fei, Iqbal, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864545/ https://www.ncbi.nlm.nih.gov/pubmed/35222001 http://dx.doi.org/10.3389/fnagi.2022.837649 |
Ejemplares similares
-
Gut Microbiota and Immunotherapy for Alzheimer’s Disease
por: Dai, Chun-Ling, et al.
Publicado: (2022) -
Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
por: Zhou, Yan, et al.
Publicado: (2018) -
Dysregulation of Protein Phosphorylation/Dephosphorylation
in Alzheimer's Disease: A Therapeutic Target
por: Gong, Cheng-Xin, et al.
Publicado: (2006) -
Intranasal Insulin Prevents Anesthesia-Induced Cognitive Impairment and Chronic Neurobehavioral Changes
por: Chen, Yanxing, et al.
Publicado: (2017) -
Chronic cerebral hypoperfusion causes decrease of O-GlcNAcylation, hyperphosphorylation of tau and behavioral deficits in mice
por: Zhao, Yang, et al.
Publicado: (2014)